FHD-286 structure
|
Common Name | FHD-286 | ||
|---|---|---|---|---|
| CAS Number | 2671128-05-3 | Molecular Weight | 562.66 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C24H30N6O6S2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of FHD-286FHD-286 is a BRG1/BRM ATPase inhibitor for the treatment of BAF-related disorders such as acute myeloid leukemia. |
| Name | FHD-286 |
|---|
| Description | FHD-286 is a BRG1/BRM ATPase inhibitor for the treatment of BAF-related disorders such as acute myeloid leukemia. |
|---|---|
| Related Catalog | |
| References |
[1]. Centore, Richard C. et al. Preparation of BRG1/BRM inhibitors for treating cancer. US20220079940 A1. |
| Molecular Formula | C24H30N6O6S2 |
|---|---|
| Molecular Weight | 562.66 |
| InChIKey | JBLQNFBXKOAIHG-FCEWJHQRSA-N |
| SMILES | COCC(NC(=O)c1ccn(S(C)(=O)=O)c1)C(=O)Nc1nc(-c2cccc(N3CC(C)OC(C)C3)n2)cs1 |
| Storage condition | 2-8°C |